OpenAI model product
GPT-Rosalind is OpenAI's life-sciences reasoning model for research.
Updated Oct 23, 2026. Default version: GPT-Rosalind
This profile uses the model's current scored version. Arena ratings and prices are shown separately.
Benchmark scores for GPT-Rosalind.
Benchmark | Score | Rank | Participants | Percentile | Evidence | Evaluated |
|---|
| BenchmarkBiorisk knowledge | Score81.10% | Rank01 | Participants1 | Percentile100.00% | EvidenceC | Evaluated |
| BenchmarkDNA sequence design for transcription factor binding | Score13.64% | Rank01 | Participants1 | Percentile100.00% | EvidenceC | Evaluated |
| BenchmarkHard negative protein binding prediction | Score3.13% | Rank01 | Participants1 | Percentile100.00% | EvidenceC | Evaluated |
| BenchmarkLabwork Bench | Score63.20% | Rank01 | Participants1 | Percentile100.00% | EvidenceC | Evaluated |
| BenchmarkMulti-select Virology Troubleshooting | Score51.20% | Rank01 | Participants1 | Percentile100.00% | EvidenceC | Evaluated |
| BenchmarkTroubleshootingBench | Score53.31% | Rank01 | Participants1 | Percentile100.00% | EvidenceC | Evaluated |
| BenchmarkProtocolQA Open-Ended | Score36.40% | Rank02 | Participants2 | Percentile0.00% | EvidenceC | Evaluated |
| BenchmarkGeneBench | Score21.60% | Rank03 | Participants3 | Percentile0.00% | EvidenceC | Evaluated |
| BenchmarkLifeSciBench | Score57.60% | Rank03 | Participants5 | Percentile50.00% | EvidenceC | Evaluated |
| BenchmarkMedChemBench (Internal) | Score27.50% | Rank04 | Participants4 | Percentile0.00% | EvidenceC | Evaluated |
Preference and agent-evaluation results for the default version.
The default version does not have a matching Arena result yet.
Official vendor API pricing appears first, followed by individual provider offers.
The default version has no current input or output token prices.
Official prices use only the vendor's configured official Provider and positive standard USD PAYG rates. Third-party offers remain explicitly labeled.
Provider-specific output speed and catalog latency for GPT-Rosalind. Runtime does not affect the capability score.
No provider-specific speed or latency record is linked to the default version yet.
Output Speed is generated output tokens received per second. Catalog latency is reported separately from observed provider TTFT.
Technical details for the model's default version.
Available versions of this model. The score column identifies the version used in the overall ranking.
Version | Released | LLMBoard | Parameters | Context | Max output | Open weights | License |
|---|
| VersionGPT-Rosalind | Released | LLMBoard50.72 | ParametersN/A | ContextN/A | Max outputN/A | Open weightsNo | LicenseProprietary |
Recommendations prioritize the same model type and family, then the closest LLMBoard score.
Key information about GPT-Rosalind and its available data.
GPT-Rosalind is a model from OpenAI designed for life sciences research, including target research, genomics and sequencing analysis, protein and sequence analysis, medicinal chemistry, literature synthesis, wet-lab troubleshooting, and experiment planning.
It combines scientific reasoning with scientific tool and database use for multi-step workflows.
Data as of 2026-10-22.
Common questions about GPT-Rosalind.
GPT-Rosalind's default version was released on Sep 11, 2026.
No official standard PAYG price is currently available for GPT-Rosalind.
GPT-Rosalind was created by OpenAI.
A context window is not available for the default version.
No. The default version is not marked as having publicly available weights.
No provider offering is currently linked to the default version.